Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewGenIvf Group's gross profit for the
three
months ended in Dec. 2025 was $0.52 Mil. NewGenIvf Group's gross profit for the trailing twelve months (TTM) ended in Dec. 2025 was $0.64 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. NewGenIvf Group's gross profit for the
three
months ended in Dec. 2025 was $0.52 Mil. NewGenIvf Group's Revenue for the
three
months ended in Dec. 2025 was $1.43 Mil. Therefore, NewGenIvf Group's Gross Margin % for the quarter that ended in Dec. 2025 was 36.77%.
NewGenIvf Group had a gross margin of 36.77% for the quarter that ended in Dec. 2025 => Competition eroding margins
During the past 5 years, the highestGross Margin % of NewGenIvf Group was 33.63%. The lowest was 20.23%. And the median was 25.87%.
NewGenIvf Group (NAS:NIVF) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
NewGenIvf Group had a gross margin of 36.77% for the quarter that ended in Dec. 2025 => Competition eroding margins
NewGenIvf Group Gross Profit Related Terms
NewGenIvf Group Gross Profit Historical Data
* Premium members only.
The historical data trend for NewGenIvf Group's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NIVF vs CDIX, RHEP, PAIYY: Gross Profit Comparison
For the Medical Care Facilities subindustry, NewGenIvf Group's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewGenIvf Group Gross Profit vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Gross Profit distribution charts can be found below:
* The bar in red indicates where NewGenIvf Group's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.64 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
NewGenIvf Group (NIVF) has a Gross Profit of $0.64 Mil as of Dec. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on NewGenIvf Group and its competitors.
Is NewGenIvf Group's Gross Profit too high?
NewGenIvf Group's current Gross Profit is $0.64 Mil. Overall, NewGenIvf Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does NewGenIvf Group's Gross Profit compare to CDIX and RHEP?
NewGenIvf Group's Gross Profit of $0.64 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Healthcare Providers & Services company?
A good Gross Profit depends on the Healthcare Providers & Services industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on NewGenIvf Group and its competitors. NewGenIvf Group's current Gross Profit is $0.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewGenIvf Group stock overvalued right now?
NewGenIvf Group (NIVF) has a current Gross Profit of $0.64 Mil. The current Gross Profit is $0.64 Mil. NewGenIvf Group's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For NewGenIvf Group (NIVF), the current Gross Profit is $0.64 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
14GF Score
Get the complete analysis for NIVF
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NIVF has been successfully added to your 
